Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP678265.RAt_GxDHPNh2yqdIgJSEcsVPw5mhgG14NzCV9sKVynDR4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP678265.RAt_GxDHPNh2yqdIgJSEcsVPw5mhgG14NzCV9sKVynDR4130_assertion type Assertion NP678265.RAt_GxDHPNh2yqdIgJSEcsVPw5mhgG14NzCV9sKVynDR4130_head.
- NP678265.RAt_GxDHPNh2yqdIgJSEcsVPw5mhgG14NzCV9sKVynDR4130_assertion description "[When the NAT1*10 heterozygote and other genotypes without NAT1*10 allele were considered as low risk genotypes, NAT1*10/NAT1*10 had a significantly higher risk of PCa (OR = 2.4, 95% CI; 1.0-5.6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678265.RAt_GxDHPNh2yqdIgJSEcsVPw5mhgG14NzCV9sKVynDR4130_provenance.
- NP678265.RAt_GxDHPNh2yqdIgJSEcsVPw5mhgG14NzCV9sKVynDR4130_assertion evidence source_evidence_literature NP678265.RAt_GxDHPNh2yqdIgJSEcsVPw5mhgG14NzCV9sKVynDR4130_provenance.
- NP678265.RAt_GxDHPNh2yqdIgJSEcsVPw5mhgG14NzCV9sKVynDR4130_assertion SIO_000772 10211944 NP678265.RAt_GxDHPNh2yqdIgJSEcsVPw5mhgG14NzCV9sKVynDR4130_provenance.
- NP678265.RAt_GxDHPNh2yqdIgJSEcsVPw5mhgG14NzCV9sKVynDR4130_assertion wasDerivedFrom befree-20140225 NP678265.RAt_GxDHPNh2yqdIgJSEcsVPw5mhgG14NzCV9sKVynDR4130_provenance.
- NP678265.RAt_GxDHPNh2yqdIgJSEcsVPw5mhgG14NzCV9sKVynDR4130_assertion wasGeneratedBy ECO_0000203 NP678265.RAt_GxDHPNh2yqdIgJSEcsVPw5mhgG14NzCV9sKVynDR4130_provenance.